Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of 59.49 billion. The enterprise value is 67.38 billion.
| Market Cap | 59.49B |
| Enterprise Value | 67.38B |
Important Dates
The last earnings date was Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 129.20M |
Valuation Ratios
The trailing PE ratio is 20.69.
| PE Ratio | 20.69 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 12.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.78, with an EV/FCF ratio of 22.57.
| EV / Earnings | 23.44 |
| EV / Sales | 2.95 |
| EV / EBITDA | 10.78 |
| EV / EBIT | 15.26 |
| EV / FCF | 22.57 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.19 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 3.57 |
| Interest Coverage | 17.84 |
Financial Efficiency
Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 6.63%.
| Return on Equity (ROE) | 9.82% |
| Return on Assets (ROA) | 5.10% |
| Return on Invested Capital (ROIC) | 6.63% |
| Return on Capital Employed (ROCE) | 10.15% |
| Revenue Per Employee | 371,110 |
| Profits Per Employee | 48,713 |
| Employee Count | 59,020 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.89 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.76% in the last 52 weeks. The beta is 0.74, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -20.76% |
| 50-Day Moving Average | 145.82 |
| 200-Day Moving Average | 162.36 |
| Relative Strength Index (RSI) | 43.17 |
| Average Volume (20 Days) | 1,471 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of 21.90 billion and earned 2.88 billion in profits. Earnings per share was 6.61.
| Revenue | 21.90B |
| Gross Profit | 12.97B |
| Operating Income | 4.23B |
| Pretax Income | 3.66B |
| Net Income | 2.88B |
| EBITDA | 5.99B |
| EBIT | 4.23B |
| Earnings Per Share (EPS) | 6.61 |
Balance Sheet
The company has 3.18 billion in cash and 10.66 billion in debt, giving a net cash position of -7.48 billion.
| Cash & Cash Equivalents | 3.18B |
| Total Debt | 10.66B |
| Net Cash | -7.48B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.05B |
| Book Value Per Share | 71.23 |
| Working Capital | 2.23B |
Cash Flow
In the last 12 months, operating cash flow was 4.75 billion and capital expenditures -1.76 billion, giving a free cash flow of 2.99 billion.
| Operating Cash Flow | 4.75B |
| Capital Expenditures | -1.76B |
| Free Cash Flow | 2.99B |
| FCF Per Share | n/a |
Margins
Gross margin is 59.20%, with operating and profit margins of 19.31% and 13.13%.
| Gross Margin | 59.20% |
| Operating Margin | 19.31% |
| Pretax Margin | 16.72% |
| Profit Margin | 13.13% |
| EBITDA Margin | 27.33% |
| EBIT Margin | 19.31% |
| FCF Margin | 13.63% |
Dividends & Yields
Merck KGaA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.13% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.83% |
| FCF Yield | 5.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck KGaA has an Altman Z-Score of 3.22.
| Altman Z-Score | 3.22 |
| Piotroski F-Score | n/a |